menu
    • menu

    Company profile for Sygnature Discovery

    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    AbbVie Contract Manufacturing partners globally to develop, scale, and manufacture pharmaceutical products successfully.

    Virtual Booth

    Contact Supplier

    Topscience Biotech is a one-stop supplier of sodium hyaluronate//drug manufacturing license, CEP, GMP, DMF, and Form 41 certifications.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Sygnature Discovery is a leading independent provider of integrated drug discovery resource and expertise. Since 2011, 35 compounds discovered by Sygnature for clients have entered pre-clinical development and so far 20 of these have progressed to clinical trials (Phases I, II and III). We add considerable value to our clients' research projects by providing intellectual input and drug discovery expertise to accelerate target...
    Sygnature Discovery is a leading independent provider of integrated drug discovery resource and expertise. Since 2011, 35 compounds discovered by Sygnature for clients have entered pre-clinical development and so far 20 of these have progressed to clinical trials (Phases I, II and III). We add considerable value to our clients' research projects by providing intellectual input and drug discovery expertise to accelerate target validation, hit identification, hit-to-lead, lead optimisation and drug discovery programmes.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Sygnature Discoveryunitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    Sygnature Discovery BioCity Pennyfoot Street Nottingham NG1 1GR
    Telephone
    Telephone
    +44 115 941 5401
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sygnaturediscovery.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sygnature-discovery
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Sygnature Discovery Partners With DaltonTx on AI Drug Discovery
    Sygnature Discovery Partners With DaltonTx on AI Drug Discovery

    11 Jun 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/digitisation/sygnature-discovery-partners-with-daltontx-to-enhance-ai-driven-drug-discovery-capabilities-20573

    INDPHARMAPOST
    11 Jun 2026
    Share Share
    DaltonTx Launches Drug Discovery Platform and Sygnature Pact
    DaltonTx Launches Drug Discovery Platform and Sygnature Pact

    04 Jun 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/06/04/3306539/0/en/daltontx-launches-its-drug-discovery-platform-dalton-and-announces-sygnature-discovery-collaboration.html

    GLOBENEWSWIRE
    04 Jun 2026
    Share Share
    Sygnature appoints Susanne Back as Head of In Vivo Pharmacology
    Sygnature appoints Susanne Back as Head of In Vivo Pharmacology

    01 Apr 2026

    // INDPHARMAPOST

    https://www.indianpharmapost.com/people/sygnature-discovery-appoints-susanne-back-as-head-of-in-vivo-pharmacology-19509

    INDPHARMAPOST
    01 Apr 2026
    Share Share
    Sygnature Discovery Reappoints Leader to Strengthen In Vivo Team
    Sygnature Discovery Reappoints Leader to Strengthen In Vivo Team

    25 Mar 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-03-25/sygnature-discovery-strengthens-in-vivo-pharmacology-leadership-with-appointment-of-susanne-back

    PHARMIWEB
    25 Mar 2026
    Share Share
    Sygnature Discovery Announces Brand Relaunch And New Website
    Sygnature Discovery Announces Brand Relaunch And New Website

    17 Feb 2026

    // EXPRESSPHARMA

    https://www.expresspharma.in/sygnature-discovery-announces-brand-relaunch-and-new-website/

    EXPRESSPHARMA
    17 Feb 2026
    Share Share
    Sygnature Discovery Unveils Strategic Rebrand To Cement Status
    Sygnature Discovery Unveils Strategic Rebrand To Cement Status

    16 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-16/sygnature-discovery-unveils-strategic-rebrand-to-cement-status-as-a-global-drug-discovery-partner

    PHARMIWEB
    16 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search